Filing Flows › Vera Therapeutics (VERA) › Who owns the stock
Who owns Vera Therapeutics (VERA) stock
217 funds reported Vera Therapeutics (VERA) shares in their latest 13F filings, worth $3.5B in all. The largest holder is BlackRock ($247M). Last quarter 118 funds added to their stakes and 94 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 5,747,760 | $247M | increase | 2026-06-30 |
| Avoro Capital Advisors LLC | 5,723,888 | $246M | decrease | 2026-06-30 |
| Vanguard Group | 3,570,401 | $181M | increase | 2025-12-31 |
| State Street | 4,148,786 | $178M | increase | 2026-06-30 |
| Price T Rowe Associates | 4,012,936 | $172M | decrease | 2026-06-30 |
| Deep Track Capital, LP | 4,000,000 | $172M | decrease | 2026-06-30 |
| Deerfield Management Company, L.P. (series C) | 3,916,400 | $168M | increase | 2026-06-30 |
| Kynam Capital Management, LP | 2,890,059 | $124M | decrease | 2026-06-30 |
| Morgan Stanley | 2,799,459 | $120M | increase | 2026-06-30 |
| Sofinnova Investments | 2,793,987 | $120M | unchanged | 2026-06-30 |
| FMR LLC | 2,774,070 | $119M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 2,755,413 | $118M | increase | 2026-06-30 |
| Eversept Partners, LP | 2,212,770 | $94.9M | increase | 2026-06-30 |
| Logos Global Management LP | 2,200,000 | $94.4M | new | 2026-06-30 |
| Integral Health Asset Management, LLC | 1,750,000 | $75.1M | increase | 2026-06-30 |
Vera Therapeutics' latest quarter
Vera Therapeutics, Q3 2026: revenue $10.3M, operating margin -931.2%, net loss $93.7M, operating cash flow −$99.2M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most VERA stock?
By the latest 13F filings: BlackRock ($247M); Avoro Capital Advisors LLC ($246M); Vanguard Group ($181M); State Street ($178M); Price T Rowe Associates ($172M).
What is the short interest in VERA?
13,587,185 shares were sold short at the 2026-10-15 settlement, -21.19% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.